Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankle

Rheumatology

Volumn 47, Issue 9, 2008, Pages 1409-1412

  Hettema, M E ^a   Zhang, D ^a   Stienstra, Y ^a   Oomen, P N H ^b   Smit, A J ^a   Kallenberg, C G M ^a   Bootsma, H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Capillary permeability; Sodium fluorescein; Systemic sclerosis; Videodensitometry

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CENTROMERE ANTIBODY; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KETANSERIN; METHOTREXATE; SCL 70 ANTIBODY;

ADULT; ANKLE; ARTICLE; BODY MASS; CAPILLARY DENSITY; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LARGE WINDOW SODIUM FLUORESCEIN VIDEODENSITOMETRY; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VIDEODENSITOMETRY;

ADULT; AGED; ANKLE; CAPILLARIES; CAPILLARY PERMEABILITY; DENSITOMETRY; FEMALE; FLUORESCEIN; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN; VIDEO RECORDING;

EID: 50849092532     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken248     Document Type: Article

References (29)

1. Herrick AL. Vascular function in systemic sclerosis. Curr Opin Rheumatol 2000;12:527-33.
2. Kahaleh MB, Leroy EC. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 1999;31:195-214.
3. Leroy EC. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 1996;22:675-94.
4. Bukhari M, Hollis S, Moore T, Jayson MI, Herrick AL. Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and Systemic sclerosis by video capillaroscopy. Rheumatology 2000;39:506-12.
5. Cutolo M, Grassi W, Matucci-Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003;48:3023-30.
6. Houtman PM, Kallenberg CG, Wouda AA, The TH. Decreased nailfold capillary density in Raynaud's phenomenon: A reflection of immunologically mediated local and systemic vascular disease? Ann Rheum Dis 1985;44:603-9.
7. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986;13:556-63.
8. Maricq HR, Spencer-Green G, Leroy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976;61:862-70.
9. Bollinger A, Jager K, Siagenthaler W. Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med 1986;146:1541-5.
10. Jager J, Oomen PH, Sluiter WJ, Reitsma WD, Smit AJ. Improved reproducibility of the 'large-window' method of assessing transcapillary and interstitial fluorescein diffusion in the skin in healthy subjects and in subjects with insulin-dependent diabetes mellitus. Int J Microcirc Clin Exp 1997;17:150-8.
11. Lefrandt JD, Bosma E, Oomen PH et al. Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy. Diabetologia 2003;46:40-7.
12. Oomen PH, Jager J, Hoogenberg K, Dullart RP, Reitsma WD, Smit AJ. Capillary permeability is increased normo- and microalbuminuric type, diabetic patients: Amelioration by ACE-inhibition. Eur J Clin Invest 1999;29:1035-40.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary Criteria for the Classification of Systemic-Sclerosis (Scleroderma). Arthritis Rheum 1986;23:681-90.
14. Grassi W, Core P, Carlino G, Blasetti P, Cervini M. Labial capillary microscopy in systemic sclerosis. Ann Rheum Dis 1993;52:564-9.
15. Scarpelli M, Montironi R, Tulli D et al. Quantitative analysis of quadriceps muscle biopsy in systemic sclerosis. Pathol Res Pract 1992;188:603-6.
16. Grassi W, Core P, Cervini C. Increased capillary permeability in systemic sclerosis: Help or hindrance? Ann Rheum Dis 1996;55:603-6.
17. Grassi W, Core P, Carlino G, Cervini C. Effects of peripheral cold exposure on microvascular dynamics in systemic sclerosis. Arthritis Rheum 1994;37:384-90.
18. Grassi W, Core P, Carlino G, Cervini C. Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclerosis. Br J Rheumatol 1994;33:1154-61.
19. Kuvin JT, Patel AR, Sidhu M et al. Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. Am J Cardiol 2003;92:275-9.
20. Toikka JO, Ahotupa M, Viikari JS et al. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis 1999;147:133-8.
21. Williams IL, Chowienczyk PJ, Wheatcroft SB et al. Effect of fat distribution on endothelial-dependent and endothelial-independent vasodilation in healthy humans. Diabetes Obes Metab 2006;8:296-301.
22. Arkin JM, Alsdorf R, Bigomia S et al. Relation of cumulative weight burden to vascular endothelial dysfunction in obesity. Am J Cardiol 2008;101:98-101.
23. Meerwaldt R, Lutgers HL, Links TP et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-12.
24. Kaloudi O, Basta G, Perfetto F et al. Circulating levels of Napsilon-(carboxymethyl) lysine are increased in systemic sclerosis. Rheumatology 2007;46:412-6.
25. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mo Med 1998;4:594-601.
26. Mulder DJ, van Haelst PL, Gross S et al. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2007;197:217-23.
27. Scheja A, Wildt M, Wollheim FA, Akesson A, Saxne T. Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement. Rheumatology 200G;39:4110-3.
28. Zurita-Salinas CS, Krotzsch E, Diaz de Leon L, Cocer-Varela J. Colagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis. Rheumatol Int 2004;24:283-90.
29. Becvar R, Hulejova H, Braun M, Stork J. Collagen degradation products and proinflammatory cytokines in systemic and localized scleroderma. Folia Biol 2007;53:66-8.